Due to health issues, this site is no longer maintained and will be shut down shortly. |
DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.
$115.80 +1.71 (1.50%)
As of 03/27/2023 14:12:47 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.